Related Experiment Videos
The hematopoietic effects of prednisone therapy in four infants with osteopetrosis
Insights
Prednisone therapy improves hematopoiesis in infants with malignant osteopetrosis. This treatment reduces liver and spleen size while increasing blood cell counts and bone marrow activity.
Area of Science:
- Pediatrics
- Hematology
- Oncology
Background:
- Malignant osteopetrosis is a rare genetic disorder characterized by impaired osteoclast function, leading to bone sclerosis and extramedullary hematopoiesis.
- Extramedullary hematopoiesis in the liver and spleen can cause organomegaly and cytopenias, contributing to the disease's severity.
- Current treatment options for malignant osteopetrosis are limited, with hematopoietic stem cell transplantation being the primary curative approach.
Purpose of the Study:
- To evaluate the efficacy of prednisone therapy in improving hematologic parameters and bone marrow function in infants with malignant osteopetrosis.
Main Methods:
- Four infants diagnosed with malignant osteopetrosis underwent sequential hematologic studies during prednisone treatment.
- Bone marrow biopsies were analyzed for changes in hematopoietic tissue quantity and quality.
- Indium 111 chloride scans were performed in one patient to assess changes in hematopoietic activity.
Main Results:
- Prednisone therapy led to decreased liver and spleen size in all infants.
- Circulating immature blood cells decreased, while hemoglobin concentration and platelet counts increased.
- Bone marrow biopsies showed improved hematopoietic tissue, which was not observed without therapy.
- Indium 111 chloride scans revealed increased long bone and pelvic uptake, with decreased liver and spleen uptake during therapy.
Conclusions:
- Prednisone therapy effectively enhances bone marrow hematopoiesis in infants with malignant osteopetrosis.
- The treatment also reduces extramedullary hematopoiesis in the liver and spleen.
- Prednisone may serve as a valuable therapeutic option for managing hematologic complications in malignant osteopetrosis.
Abstract:
Sequential hematologic studies were performed in four infants with malignant osteopetrosis who received prednisone. Prednisone therapy resulted in decreased liver and spleen size, decreased numbers of circulating immature blood cells, and increased hemoglobin concentration and platelet counts in all infants. The quantity and quality of hematopoietic tissue in bone marrow biopsies improved during prednisone therapy but showed no significant improvement without therapy. Sequential indium 111 chloride scans in one infant showed increased uptake in long bones and pelvis and decreased uptake in liver and spleen during therapy. We conclude that prednisone therapy of infantile osteopetrosis results in increased bone marrow hematopoiesis and decreased extramedullary hematopoiesis.